Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? için istatistikler

Toplam ziyaret

views
Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? 2

Aylık toplam ziyaret

views
Mayıs 2026 0
Haziran 2026 2
Temmuz 2026 0
Ağustos 2026 0
Eylül 2026 0
Ekim 2026 0
Kasım 2026 0